Michael P. Castro, MD

Cancer treatment today begins with comprehensive molecular diagnosis and addresses all of the driver and resistance mechanisms in the disease. As no two patients are alike, precision medicine requires individualized therapeutic design. Patient-centric oncology is not limited by practice guidelines but instead aims at achieving superior outcomes by bringing together breakthrough scientific insight and molecular diagnostics rather than merely complying with norms that were developed in advance of today's understanding of cancer biology.

Concierge level services are available for patients seeking comprehensive molecular insight into their disease mechanisms and therapeutic vulnerabilities. Design of a program that is not limited by insurance reimbursement or conventional institutional bias will be provided.